Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the autoinjectors market grown in recent years?
The market size for autoinjectors has seen rapid expansion in the past few years. The market growth is projected to increase from $3.7 billion in 2024 to $4.55 billion in 2025, with a compound annual growth rate (CAGR) of 22.8%. The expansion witnessed in the historic timespan has been impacted by several factors including a higher incidence of chronic illnesses, an increase in the aged population, growth in biotechnology and pharmaceutical sectors, patient inclination towards self-administration, and regulatory support.
How is the autoinjectors market size expected to evolve during the forecast period?
The market for autoinjectors is predicted to undergo substantial growth in the forthcoming years, escalating to $10.07 billion by 2029 with a compound annual growth rate (CAGR) of 22.0%. The growth over the forecast period can be ascribed to the extension of therapeutic applications, surging healthcare expenses, heightened emphasis on patient-specific care, evolution of telemedicine and distant patient supervision, as well as emerging markets. Prevalent trends in the projected period encompass personalized medication distribution, integrated and intelligent autoinjectors, autoinjectors without needles, biologic drug administration, and safety and security facets.
Get your autoinjectors market report here!
https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report
Which key drivers are propelling the autoinjectors market’s growth?
The increasing prevalence of chronic diseases is expected to fuel the growth of the autoinjectors market in the coming years. Chronic diseases are described as illnesses that last a year or longer and necessitate continuing medical attention. Chronic diseases such as heart disease, cancer, rheumatoid arthritis, and diabetes are the world’s top causes of mortality and disability. Auto injection devices are intended for multiple injections of biologics and hormones in patients who require regular dosage for long-term management of medical circumstances such as diabetes and rheumatoid arthritis. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, in the US, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in 2022. It is about 1,670 fatalities each day. This increasing prevalence of chronic diseases drives the growth of the autoinjectors market, as these devices provide a convenient and effective solution for patients needing regular medication.
What are the market segments in the autoinjectors industry?
The autoinjectors market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Disposable Autoinjectors, Reusable Autoinjectors_x000D_
2) By Therapy: Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies_x000D_
3) By Route Of Administration: Subcutaneous, Intramuscular_x000D_
4) By Distribution Channel: Online Retailer, Pharmacy_x000D_
5) By End User: Home Care Settings, Hospitals And Clinics, Other End-Users _x000D_
_x000D_
Subsegments:_x000D_
1) By Disposable Autoinjectors: Single-Use Disposable Autoinjectors, Pre-filled Disposable Autoinjectors _x000D_
2) By Reusable Autoinjectors: Multi-Use Reusable Autoinjectors, Rechargeable Reusable Autoinjectors
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5249&type=smp
Which leading companies are shaping the growth of the autoinjectors market?
Major companies operating in the autoinjectors market include AbbVie Inc., Mylan N.V., Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Pfizer Inc., Bayer AG, Biogen Inc., AstraZeneca PLC, Haselmeier GmbH, Owen Mumford Ltd., Gerresheimer AG, Philip Morris International Inc., Oval Medical Technologies Ltd., Solteam Incorporation Co. Ltd., Elcam Medical Group (E3D) Ltd., Jabil Inc., Catalent Inc., SHL Medical AG, West Pharmaceutical Services Inc., Nemera Development S.A., Bespak Europe Ltd., AptarGroup Inc., Consort Medical plc, Terumo Corporation, Nipro Corporation, Medtronic plc, Integra LifeSciences Corporation, OssDsign AB, Xenco Medical LLC, Renishaw plc
What key trends are currently impacting the autoinjectors market’s development?
Advancements in technology are progressively shaping the autoinjectors market. The significant entities in the autoinjectors industry are concentrating on generating technical enhancements to meet the need for a robust delivery mechanism of viscous biologics. For instance, in May 2023, the U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim’s Cyltezo Pen, underlining the German pharmaceutical’s strides in the autoinjector market. The company’s Cyltezo (adalimumab-adbm), used for treating several chronic inflammatory diseases, is incorporated in the Cyltezo Pen. This 40 mg/0.8 mL pre-filled device will be made available in two, four and six packs.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5249
Which geographic areas are influencing the growth of the autoinjectors market?
North America was the largest region in the autoinjectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autoinjectors market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Product Engineering Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/product-engineering-services-global-market-report
IoT in Manufacturing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report
Ventricular Assist Device Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
